- Trial Watch: Toll-like receptor agonists for cancer therapy.
Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Oncoimmunology. 2013 Aug 1;2(8):e25238. doi: 10.4161/onci.25238. Epub 2013 Jun 10. Oncoimmunology. 2013. PMID: 24083080 Free PMC article. Review.
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.
Khalil DN, Smith EL, Brentjens RJ, Wolchok JD. Khalil DN, et al. Nat Rev Clin Oncol. 2016 May;13(5):273-90. doi: 10.1038/nrclinonc.2016.25. Epub 2016 Mar 15. Nat Rev Clin Oncol. 2016. PMID: 26977780 Free PMC article. Review.
- Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy.
Aranda F, Vacchelli E, Eggermont A, Galon J, Fridman WH, Zitvogel L, Kroemer G, Galluzzi L. Aranda F, et al. Oncoimmunology. 2014 Jan 1;3(1):e27297. doi: 10.4161/onci.27297. Epub 2014 Feb 1. Oncoimmunology. 2014. PMID: 24701370 Free PMC article.
- Classification of current anticancer immunotherapies.
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G. Galluzzi L, et al. Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.
- Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.
Aghlara-Fotovat S, Nash A, Kim B, Krencik R, Veiseh O. Aghlara-Fotovat S, et al. Drug Deliv Transl Res. 2021 Dec;11(6):2394-2413. doi: 10.1007/s13346-021-01018-0. Epub 2021 Jun 26. Drug Deliv Transl Res. 2021. PMID: 34176099 Review.